Search Results
Mar 28, 2026, 10:44 ET SLNO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
LLP, a leading national securities law firm, is investigating potential claims against Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO) and reminds investors of the May 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed
More news about: Faruqi & Faruqi, LLP
Mar 27, 2026, 22:42 ET Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NasdaqCM: SLNO) of a class action securities lawsuit.
More news about: Kahn Swick & Foti, LLC
Mar 26, 2026, 17:50 ET Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman
SLNO Investors with Losses Encouraged to Contact the FirmSAN FRANCISCO, March 26, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Soleno Therapeutics, Inc. (NASDAQ: SLNO) seeking
More news about: Hagens Berman Sobol Shapiro LLP
Mar 26, 2026, 16:45 ET SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between March 26, 2025 and November 4, 2025, both dates inclusive (the "Class Period"), of the important May 5, 2026 lead plaintiff deadline.So
More news about: THE ROSEN LAW FIRM, P. A.
Mar 26, 2026, 13:30 ET SLNO Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages SLNO Investors with Losses to Contact the Firm
Did you buy SLNO common stock between March 26, 2025, and November 4, 2025?Affected Soleno Therapeutics, Inc. Investor SummaryWho: Soleno Therapeutics, Inc. (
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 26, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SLNO
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-soleno-therapeutics-inc-of-class-action-lawsuit-and-upcoming-deadlines--slno-302725669.htmlSOURCE
More news about: Pomerantz LLP
Mar 26, 2026, 09:00 ET SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting DCCR Safety Timeline: SueWallSt
March 26, 2026 /PRNewswire/ -- SueWallSt encourages investors who suffered losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO) to contact the firm. Those who purchased SLNO securities between March 26, 2025 and November 4, 2025 may be entitled to recover damages.
More news about: SueWallSt.com
Mar 25, 2026, 17:01 ET Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
SLNO).
More news about: Glancy Prongay Wolke & Rotter LLP
Mar 25, 2026, 09:00 ET SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Conducting Sham Clinical Trials: Levi & Korsinsky
March 25, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Soleno Therapeutics, Inc. (NASDAQ: SLNO) securities of a pending securities class action.
More news about: Levi & Korsinsky, LLP
Mar 24, 2026, 12:36 ET Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman
SLNO Investors with Losses Encouraged to Contact Hagens BermanSAN FRANCISCO, March 24, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Soleno Therapeutics, Inc. (NASDAQ: SLNO) seeking
More news about: Hagens Berman Sobol Shapiro LLP
Mar 24, 2026, 09:00 ET SLNO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Soleno Therapeutics, Inc. Securities Lawsuit -- The Gross Law Firm
March 24, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Soleno Therapeutics, Inc. (NASDAQ: SLNO).
More news about: The Gross Law Firm
Mar 23, 2026, 22:16 ET Robbins LLP Urges SLNO Stockholders Who Lost Money Investing in Soleno Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action
Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Soleno Therapeutics (NASDAQ: SLNO) common stock between March 26, 2025 and November 4, 2025. Soleno is a pharmaceutical company focused on developing therapies for rare diseases. The
More news about: Robbins LLP
Mar 23, 2026, 21:07 ET SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between March 26, 2025 through November 4, 2025, both dates inclusive (the "Class Period"), of the important May 5, 2026 lead plaintiff deadline.So
More news about: THE ROSEN LAW FIRM, P. A.
Mar 23, 2026, 02:11 ET Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO
Inc. ("Soleno" or "the Company") (NASDAQ: SLNO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of SLNO during the class period listed are encouraged
More news about: DJS Law Group LLP
Mar 23, 2026, 02:02 ET SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
SLNO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange
More news about: The Schall Law Firm
Mar 22, 2026, 08:25 ET SLNO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
LLP, a leading national securities law firm, is investigating potential claims against Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO) and reminds investors of the May 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed
More news about: Faruqi & Faruqi, LLP
Mar 20, 2026, 22:36 ET Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO
Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NasdaqCM: SLNO), if they purchased or otherwise acquired the Company's shares between March 26, 2025 and November 4, 2025, inclusive (the "Class Period"). This action
More news about: ClaimsFiler
Mar 20, 2026, 16:20 ET Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman
SLNO Investors with Losses Encouraged to Contact the FirmSAN FRANCISCO, March 20, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Soleno Therapeutics, Inc. (NASDAQ: SLNO) seeking
More news about: Hagens Berman Sobol Shapiro LLP
Mar 20, 2026, 16:07 ET Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
SLNO). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN SOLENO THERAPEUTICS, INC. (SLNO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE MAY 5, 2026 (LEAD PLAINTIFF DEADLINE)
More news about: Law Offices of Howard G. Smith
Mar 20, 2026, 12:26 ET NASDAQ: SLNO: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Soleno Therapeutics, Inc.
Did you buy SLNO common stock between March 26, 2025, and November 4, 2025?Affected Soleno Therapeutics, Inc. Investor SummaryWho: Soleno Therapeutics, Inc. (
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 20, 2026, 04:10 ET SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
SLNO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange
More news about: The Schall Law Firm
Mar 20, 2026, 04:07 ET Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO
SLNO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of SLNO during the class period listed are encouraged
More news about: DJS Law Group LLP
Mar 20, 2026, 03:06 ET SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
SLNO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange
More news about: The Schall Law Firm
Mar 19, 2026, 21:54 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SLNO
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-soleno-therapeutics-inc-of-class-action-lawsuit-and-upcoming-deadlines--slno-302719270.htmlSOURCE
More news about: Pomerantz LLP
Mar 19, 2026, 09:00 ET SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Conducting Sham Clinical Trials: SueWallSt
YORK, March 19, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of Soleno Therapeutics, Inc. (NASDAQ: SLNO) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased Soleno securities
More news about: SueWallSt.com